Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1-Reference-Cited by-同舟云学术

Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1

Published:2020-05-08 Issue:6 Volume:15 Page:1505-1516
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Puhl Ana C.¹,Bogart Jonathan W.¹,Haberman Victoria A.¹,Larson Jacob E.¹,Godoy Andre S.²^ORCID,Norris-Drouin Jacqueline L.¹,Cholensky Stephanie H.¹,Leisner Tina M.³,Frye Stephen V.¹⁴^ORCID,Parise Leslie V.³⁴,Bowers Albert A.¹⁴⁵^ORCID,Pearce Kenneth H.¹⁴

Affiliation:

1. Center for Integrative Chemical Biology and Drug Discovery, Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States

2. Institute of Physics of São Carlos, University of São Paulo, Av. Joao Dagnone, 1100 − Jardim Santa Angelina, São Carlos 13563-120, Brazil

3. Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, United States

4. UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599, United States

5. Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

North Carolina Biotechnology Center

Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.0c00144

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

3. Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients

4. Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies

5. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot;Nature Communications;2024-07-02

2. Small-Molecule Disruptors of the Interaction between Calcium- and Integrin-Binding Protein 1 and Integrin α_IIbβ₃ as Novel Antiplatelet Agents;ACS Pharmacology & Translational Science;2024-05-29

3. Discovery of FERM domain protein–protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer’s disease;Journal of Biological Chemistry;2023-12

4. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer;Frontiers in Immunology;2023-08-25

5. Identification of Covalent Cyclic Peptide Inhibitors in mRNA Display;Journal of the American Chemical Society;2023-07-03